tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lee Hambright, 36 are a HOLD (33.03%), 70 are a BUY (64.22%), 3 are a SELL (2.75%).
Analyst Lee Hambright, currently employed at BERNSTEIN, carries an average stock price target met ratio of 61.72% that have a potential upside of 18.94% achieved within 236 days.
Lee Hambright’s has documented 217 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PODD, Insulet at 06-Aug-2026.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/10/2025. The price target of $18 was fulfilled within 2 days with a profit of $1.63 (9.96%) receiving and performance score of 49.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Oct-2015
$110
$23.4 (27.02%)
$110
16 days ago
(07-Oct-2026)
23/34 (67.65%)
$24.22 (28.24%)
273
Buy Since 25-Nov-2025
$110
$23.4 (27.02%)
$110
1 months 12 days ago
(11-Sep-2026)
0/7 (0%)
$25.63 (30.38%)
Hold Since 11-Oct-2024
$110
$23.4 (27.02%)
$86
2 months 25 days ago
(28-Jul-2026)
6/11 (54.55%)
$26.32 (31.45%)
42
Buy Since 13-May-2025
$101
$14.4 (16.63%)
$100
2 months 29 days ago
(24-Jul-2026)
29/34 (85.29%)
$18.37 (22.23%)
145
Buy Since 24-Jul-2026
$105
$18.4 (21.25%)
$100
2 months 29 days ago
(24-Jul-2026)
7/11 (63.64%)
$22.37 (27.07%)
188
Which stock is Lee Hambright most bullish on?
Which stock is Lee Hambright most reserved on?
What Year was the first public recommendation made by Lee Hambright?
